Current status of antiangiogenic factors

被引:76
作者
Talks, KL [1 ]
Harris, AL [1 ]
机构
[1] John Radcliffe Hosp, Inst Mol Med, ICRF Med Oncol Unit, Growth Factors Grp, Oxford OX3 9DU, England
关键词
D O I
10.1046/j.1365-2141.2000.01864.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:477 / 489
页数:13
相关论文
共 155 条
[1]  
Aguayo A, 1998, BLOOD, V92, p607A
[2]   COMPARATIVE EXPRESSION OF FIBROBLAST GROWTH-FACTOR MESSENGER-RNAS IN BENIGN AND MALIGNANT BREAST DISEASE [J].
ANANDAPPA, SY ;
WINSTANLEY, JHR ;
LEINSTER, S ;
GREEN, B ;
RUDLAND, PS ;
BARRACLOUGH, R .
BRITISH JOURNAL OF CANCER, 1994, 69 (04) :772-776
[3]  
ANDRADE SP, 1987, BRIT J EXP PATHOL, V68, P755
[4]   Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].
Arap, W ;
Pasqualini, R ;
Ruoslahti, E .
SCIENCE, 1998, 279 (5349) :377-380
[5]   Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways [J].
Arbiser, JL ;
Moses, MA ;
Fernandez, CA ;
Ghiso, N ;
Cao, YH ;
Klauber, N ;
Frank, D ;
Brownlee, M ;
Flynn, E ;
Parangi, S ;
Byers, HR ;
Folkman, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (03) :861-866
[6]  
Arora N, 1999, CANCER RES, V59, P183
[7]   Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology [J].
Banks, RE ;
Forbes, MA ;
Kinsey, SE ;
Stanley, A ;
Ingham, E ;
Walters, C ;
Selby, PJ .
BRITISH JOURNAL OF CANCER, 1998, 77 (06) :956-964
[8]  
Bellamy WT, 1999, CANCER RES, V59, P728
[9]   INDUCTION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION IN SYNOVIAL FIBROBLASTS BY PROSTAGLANDIN-E AND INTERLEUKIN-1 - A POTENTIAL MECHANISM FOR INFLAMMATORY ANGIOGENESIS [J].
BENAV, P ;
CROFFORD, LJ ;
WILDER, RL ;
HLA, T .
FEBS LETTERS, 1995, 372 (01) :83-87
[10]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165